192 related articles for article (PubMed ID: 19371627)
1. Chromium reduces the in vitro activity and fidelity of DNA replication mediated by the human cell DNA synthesome.
Dai H; Liu J; Malkas LH; Catalano J; Alagharu S; Hickey RJ
Toxicol Appl Pharmacol; 2009 Apr; 236(2):154-65. PubMed ID: 19371627
[TBL] [Abstract][Full Text] [Related]
2. Ara-C affects formation of cancer cell DNA synthesome replication intermediates.
Abdel-Aziz W; Jiang HY; Hickey RJ; Malkas LH
Cancer Chemother Pharmacol; 2000; 45(4):312-9. PubMed ID: 10755320
[TBL] [Abstract][Full Text] [Related]
3. An in vitro model system that can differentiate the stages of DNA replication affected by anticancer agents.
Abdel-Aziz W; Hickey RJ; Malkas LH
Biochem Pharmacol; 2004 Jul; 68(1):11-21. PubMed ID: 15183113
[TBL] [Abstract][Full Text] [Related]
4. Effects of gemcitabine and araC on in vitro DNA synthesis mediated by the human breast cell DNA synthesome.
Jiang HY; Hickey RJ; Abdel-Aziz W; Malkas LH
Cancer Chemother Pharmacol; 2000; 45(4):320-8. PubMed ID: 10755321
[TBL] [Abstract][Full Text] [Related]
5. Differential inhibition of the human cell DNA replication complex-associated DNA polymerases by the antimetabolite 1-beta-D-arabinofuranosylcytosine triphosphate (ara-CTP).
Han S; Hickey RJ; Tom TD; Wills PW; Syväoja JE; Malkas LH
Biochem Pharmacol; 2000 Aug; 60(3):403-11. PubMed ID: 10856436
[TBL] [Abstract][Full Text] [Related]
6. Mercuric ion inhibits the activity and fidelity of the human cell DNA synthesome.
Sekowski JW; Malkas LH; Wei Y; Hickey RJ
Toxicol Appl Pharmacol; 1997 Aug; 145(2):268-76. PubMed ID: 9266799
[TBL] [Abstract][Full Text] [Related]
7. The isolation of a DNA synthesome from human leukemia cells.
Lin S; Hickey RJ; Malkas LH
Leuk Res; 1997 Jun; 21(6):501-12. PubMed ID: 9279361
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of a DNA synthesome from a neuroblastoma cell line.
Sandoval JA; Hickey RJ; Malkas LH
J Pediatr Surg; 2005 Jul; 40(7):1070-7. PubMed ID: 16034747
[TBL] [Abstract][Full Text] [Related]
9. Mapping specific protein-protein interactions within the core component of the breast cell DNA synthesome.
Coll JM; Hickey RJ; Cronkey EA; Jiang HY; Schnaper L; Lee MY; Uitto L; Syvaoja JE; Malkas LH
Oncol Res; 1997; 9(11-12):629-39. PubMed ID: 9563011
[TBL] [Abstract][Full Text] [Related]
10. Ara-C differentially affects multiprotein forms of human cell DNA polymerase.
Wills PW; Hickey R; Malkas L
Cancer Chemother Pharmacol; 2000; 46(3):193-203. PubMed ID: 11021736
[TBL] [Abstract][Full Text] [Related]
11. The human breast cell DNA synthesome: its purification from tumor tissue and cell culture.
Coll JM; Sekowski JW; Hickey RJ; Schnaper L; Yue W; Brodie AM; Uitto L; Syvaoja JE; Malkas LH
Oncol Res; 1996; 8(10-11):435-47. PubMed ID: 9114436
[TBL] [Abstract][Full Text] [Related]
12. The biochemical status of the DNA synthesome can distinguish between permanent and temporary cell growth arrest.
Lin S; Hickey R; Malkas L
Cell Growth Differ; 1997 Dec; 8(12):1359-69. PubMed ID: 9419424
[TBL] [Abstract][Full Text] [Related]
13. Partial Purification of a Megadalton DNA Replication Complex by Free Flow Electrophoresis.
Li CM; Miao Y; Lingeman RG; Hickey RJ; Malkas LH
PLoS One; 2016; 11(12):e0169259. PubMed ID: 28036377
[TBL] [Abstract][Full Text] [Related]
14. Mutational spectrum induced by chromium(III) in shuttle vectors replicated in human cells: relationship to Cr(III)-DNA interactions.
Tsou TC; Lin RJ; Yang JL
Chem Res Toxicol; 1997 Sep; 10(9):962-70. PubMed ID: 9305577
[TBL] [Abstract][Full Text] [Related]
15. Characterization of RNA primers synthesized by the human breast cancer cell DNA synthesome.
Dai H; Liu J; Malkas LH; Hickey RJ
J Cell Biochem; 2009 Apr; 106(5):798-811. PubMed ID: 19204933
[TBL] [Abstract][Full Text] [Related]
16. Chromium(III) bound to DNA templates promotes increased polymerase processivity and decreased fidelity during replication in vitro.
Snow ET; Xu LS
Biochemistry; 1991 Nov; 30(47):11238-45. PubMed ID: 1958661
[TBL] [Abstract][Full Text] [Related]
17. DNA polymerase zeta is essential for hexavalent chromium-induced mutagenesis.
O'Brien TJ; Witcher P; Brooks B; Patierno SR
Mutat Res; 2009 Apr; 663(1-2):77-83. PubMed ID: 19428373
[TBL] [Abstract][Full Text] [Related]
18. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells.
Quievryn G; Peterson E; Messer J; Zhitkovich A
Biochemistry; 2003 Feb; 42(4):1062-70. PubMed ID: 12549927
[TBL] [Abstract][Full Text] [Related]
19. The DNA synthesome: its potential as a novel in vitro model system for studying S-phase specific anticancer agents.
Abdel-Aziz W; Malkas LH; Wills PW; Hickey RJ
Crit Rev Oncol Hematol; 2003 Oct; 48(1):19-33. PubMed ID: 14585481
[TBL] [Abstract][Full Text] [Related]
20. Chromium(III) decreases the fidelity of human DNA polymerase beta.
Singh J; Snow ET
Biochemistry; 1998 Jun; 37(26):9371-8. PubMed ID: 9649318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
